SAN DIEGO--(BUSINESS WIRE)-- Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision ...
Bangor Daily News and the Maine Monitor in 2025 as a rural government reporter through Report For America. He is based in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results